Latest News

  • Beyond the Brain Scan: How Emerging Blood Tests Could Change the Way Neurodegenerative Diseases are Detected and Diagnosed Down the Road

    Diagnostics World | We have entered a new era of science focused on developing tools and technologies to support early detection and diagnosis. The rapid evolution of research has led to the need to systematically collect, review, and distill findings into clear and actionable recommendations for how to use these tools in clinical practice

    Oct 1, 2025

  • ‘Super-Simple’ NLP Model Labels Origin of Metastatic Cancer

    Diagnostics World | For patients with metastatic brain cancer, stereotactic radiosurgery has become an increasingly common treatment over the past decade based on the recommendations of medical physicists, guidelines of professional societies, and coverage guidelines of federal agencies. There has also been a change in the drugs used to treat the underlying cancer in conjunction with the procedure, especially in cases of metastatic cancer.

    Sep 30, 2025

  • GE Healthcare Acquires icometrix, Beckman Coulter Launches First Fully Automated BD-Tau Immunoassay Test, More

    Diagnostics World | GE HealthCare enters an agreement to acquire icometrix; Beckman Coulter Diagnostics launches the industry's first fully automated brain-derived Tau (BD-Tau) research use only (RUO) immunoassay test; and more.

    Sep 25, 2025

  • GE Healthcare Acquires icometrix, Beckman Coulter Launches First Fully Automated BD-Tau Immunoassay Test, More

    Diagnostics World | GE HealthCare enters an agreement to acquire icometrix; Beckman Coulter Diagnostics launches the industry's first fully automated brain-derived Tau (BD-Tau) research use only (RUO) immunoassay test; and more.

    Sep 25, 2025

  • Follow the Money: Blood-Based Ovarian Cancer Test, Esophageal Diagnostic Platform, More

    Diagnostics World | Mercy BioAnalytics will commercialize their blood-based ovarian cancer test portfolio; Cyted Health will accelerate the commercial expansion of their diagnostics platform in the U.S.; and more.

    Sep 24, 2025

  • Apple Watch Receives FDA Clearance for Hypertension Notifications

    Diagnostics World | Last week Apple introduced Apple Watch Series 11, offering the most comprehensive set of health features yet, longer battery life, an even more durable cover glass, and 5G cellular capabilities, all in its thinnest and most comfortable design. Among the new features, Apple Watch Series 11 introduced FDA-cleared hypertension notifications, which can alert users if signs of chronic high blood pressure — or hypertension — are detected.

    Sep 18, 2025

  • Biomarker Combo Could Guide Treatment of Recurring Ovarian Cancer

    Diagnostics World | Ovarian cancer relapse is a remarkably diverse and dynamic immunological event that when mapped in conjunction with the genomic characteristic of tumors can provide actionable insights about how to enhance the effectiveness of chemotherapy in extending remission and prolonging survival. That’s the promising possibility suggested by researchers in the field who have newly defined four immunologic subtypes of recurrent ovarian cancers.

    Sep 17, 2025

  • AI-Stethoscope Increases Cardiac Condition Diagnoses in Routine Care

    Diagnostics World | Results from one of the largest randomized evaluations of AI in routine care showed that an AI-enabled digital stethoscope significantly increased the number of major cardiac conditions detected compared to the standard of care. The study was led by Imperial College London and Imperial College Healthcare NHS Trust and the results were presented last week at the European Society of Cardiology Congress in Madrid.

    Sep 16, 2025